Rank | Gene Set | Z-score |
---|---|---|
1 | purine nucleobase biosynthetic process (GO:0009113) | 6.32604722 |
2 | nucleobase biosynthetic process (GO:0046112) | 5.33325099 |
3 | folic acid metabolic process (GO:0046655) | 5.17652035 |
4 | folic acid transport (GO:0015884) | 5.13888523 |
5 | pantothenate metabolic process (GO:0015939) | 5.04066914 |
6 | glycine metabolic process (GO:0006544) | 5.01325725 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99687557 |
8 | negative regulation of cell killing (GO:0031342) | 4.99687557 |
9 | serine family amino acid catabolic process (GO:0009071) | 4.90696313 |
10 | ribosome assembly (GO:0042255) | 4.75895970 |
11 | amino acid salvage (GO:0043102) | 4.69908549 |
12 | L-methionine salvage (GO:0071267) | 4.69908549 |
13 | L-methionine biosynthetic process (GO:0071265) | 4.69908549 |
14 | NADH metabolic process (GO:0006734) | 4.68706264 |
15 | vitamin transmembrane transport (GO:0035461) | 4.65791188 |
16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44906907 |
17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.41941689 |
18 | cytidine deamination (GO:0009972) | 4.37865377 |
19 | cytidine metabolic process (GO:0046087) | 4.37865377 |
20 | cytidine catabolic process (GO:0006216) | 4.37865377 |
21 | serine family amino acid metabolic process (GO:0009069) | 4.27355337 |
22 | serine family amino acid biosynthetic process (GO:0009070) | 4.23123347 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.20825080 |
24 | formation of translation preinitiation complex (GO:0001731) | 4.03229103 |
25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.02476981 |
26 | sulfur amino acid biosynthetic process (GO:0000097) | 4.01036056 |
27 | ribosome biogenesis (GO:0042254) | 3.98689840 |
28 | L-serine metabolic process (GO:0006563) | 3.96052636 |
29 | methionine metabolic process (GO:0006555) | 3.94706362 |
30 | DNA deamination (GO:0045006) | 3.93924709 |
31 | proteasome assembly (GO:0043248) | 3.87643741 |
32 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.86380111 |
33 | rRNA modification (GO:0000154) | 3.80732922 |
34 | methionine biosynthetic process (GO:0009086) | 3.79471494 |
35 | cysteine metabolic process (GO:0006534) | 3.78688506 |
36 | sulfur amino acid catabolic process (GO:0000098) | 3.78470212 |
37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.73056187 |
38 | L-phenylalanine metabolic process (GO:0006558) | 3.73056187 |
39 | biotin metabolic process (GO:0006768) | 3.71754054 |
40 | termination of RNA polymerase III transcription (GO:0006386) | 3.70334774 |
41 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.70334774 |
42 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.67066508 |
43 | cofactor transport (GO:0051181) | 3.66135531 |
44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66076725 |
45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.58495465 |
46 | L-phenylalanine catabolic process (GO:0006559) | 3.58495465 |
47 | neutrophil activation involved in immune response (GO:0002283) | 3.57738767 |
48 | S-adenosylmethionine metabolic process (GO:0046500) | 3.57341752 |
49 | positive regulation of defense response to virus by host (GO:0002230) | 3.53052651 |
50 | heme transport (GO:0015886) | 3.52442544 |
51 | modified amino acid transport (GO:0072337) | 3.52134902 |
52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52073866 |
53 | maturation of SSU-rRNA (GO:0030490) | 3.44590333 |
54 | cellular response to interleukin-15 (GO:0071350) | 3.42846625 |
55 | response to xenobiotic stimulus (GO:0009410) | 3.40239301 |
56 | 7-methylguanosine mRNA capping (GO:0006370) | 3.38887694 |
57 | transcription from mitochondrial promoter (GO:0006390) | 3.36287413 |
58 | sulfur amino acid metabolic process (GO:0000096) | 3.35986014 |
59 | transcription from RNA polymerase I promoter (GO:0006360) | 3.35093250 |
60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34895327 |
61 | autophagic vacuole assembly (GO:0000045) | 3.34874706 |
62 | termination of RNA polymerase I transcription (GO:0006363) | 3.33886876 |
63 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.32569720 |
64 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.30073726 |
65 | amino-acid betaine metabolic process (GO:0006577) | 3.29941112 |
66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.28783083 |
67 | regulation of translation in response to stress (GO:0043555) | 3.27678274 |
68 | granulocyte activation (GO:0036230) | 3.27060768 |
69 | response to interferon-beta (GO:0035456) | 3.26696606 |
70 | mitotic metaphase plate congression (GO:0007080) | 3.25748252 |
71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24186719 |
72 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.23414047 |
73 | aromatic amino acid family catabolic process (GO:0009074) | 3.22844774 |
74 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.22677828 |
75 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.22497998 |
76 | neutrophil activation (GO:0042119) | 3.22425989 |
77 | response to interleukin-15 (GO:0070672) | 3.22171098 |
78 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.21917970 |
79 | RNA capping (GO:0036260) | 3.21301017 |
80 | 7-methylguanosine RNA capping (GO:0009452) | 3.21301017 |
81 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.18894140 |
82 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.18846291 |
83 | intestinal epithelial cell development (GO:0060576) | 3.16575117 |
84 | regulation of spindle organization (GO:0090224) | 3.15993386 |
85 | regulation of G0 to G1 transition (GO:0070316) | 3.14495398 |
86 | cellular metabolic compound salvage (GO:0043094) | 3.14150104 |
87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13780560 |
88 | negative regulation of innate immune response (GO:0045824) | 3.13763532 |
89 | vitamin transport (GO:0051180) | 3.11633734 |
90 | GMP metabolic process (GO:0046037) | 3.10140088 |
91 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.07032386 |
92 | lung-associated mesenchyme development (GO:0060484) | 3.06390285 |
93 | aromatic amino acid family metabolic process (GO:0009072) | 3.04955408 |
94 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03606847 |
95 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.02960933 |
96 | urate metabolic process (GO:0046415) | 3.02744197 |
97 | negative regulation of interleukin-12 production (GO:0032695) | 3.02510168 |
98 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.01991599 |
99 | branched-chain amino acid catabolic process (GO:0009083) | 3.00528274 |
100 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.00256982 |
101 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.98072653 |
102 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.97606475 |
103 | fructose metabolic process (GO:0006000) | 2.97485184 |
104 | negative regulation of interleukin-1 production (GO:0032692) | 2.94438398 |
105 | tryptophan catabolic process (GO:0006569) | 2.93807718 |
106 | indole-containing compound catabolic process (GO:0042436) | 2.93807718 |
107 | indolalkylamine catabolic process (GO:0046218) | 2.93807718 |
108 | aspartate family amino acid metabolic process (GO:0009066) | 2.93437508 |
109 | negative regulation of interleukin-6 production (GO:0032715) | 2.93008619 |
110 | autophagic vacuole fusion (GO:0000046) | 2.92963320 |
111 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.91870996 |
112 | interferon-gamma secretion (GO:0072643) | 2.90413224 |
113 | positive thymic T cell selection (GO:0045059) | 2.89727667 |
114 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89078414 |
115 | tolerance induction (GO:0002507) | 2.88053235 |
116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88002514 |
117 | GDP-mannose metabolic process (GO:0019673) | 2.87747588 |
118 | positive regulation of ligase activity (GO:0051351) | 2.86823057 |
119 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.86306091 |
120 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.86189701 |
121 | kynurenine metabolic process (GO:0070189) | 2.85463694 |
122 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85406235 |
123 | DNA replication checkpoint (GO:0000076) | 2.84834497 |
124 | rRNA methylation (GO:0031167) | 2.84524897 |
125 | negative regulation of ligase activity (GO:0051352) | 2.84064962 |
126 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.84064962 |
127 | rRNA processing (GO:0006364) | 2.83694566 |
128 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79800652 |
129 | alpha-amino acid catabolic process (GO:1901606) | 2.79687879 |
130 | positive regulation of protein homooligomerization (GO:0032464) | 2.78792213 |
131 | cellular amino acid catabolic process (GO:0009063) | 2.78721975 |
132 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.78358182 |
133 | labyrinthine layer development (GO:0060711) | 2.78322895 |
134 | regulation of defense response to virus by host (GO:0050691) | 2.78318336 |
135 | cellular response to interferon-beta (GO:0035458) | 2.77356330 |
136 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.76818275 |
137 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.76818275 |
138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.76355988 |
139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.76355988 |
140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.76355988 |
141 | modulation by symbiont of host immune response (GO:0052553) | 2.76355988 |
142 | positive regulation by symbiont of host defense response (GO:0052509) | 2.76355988 |
143 | modulation by symbiont of host defense response (GO:0052031) | 2.76355988 |
144 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.75966407 |
145 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.75548473 |
146 | leukocyte degranulation (GO:0043299) | 2.74616271 |
147 | homocysteine metabolic process (GO:0050667) | 2.74177649 |
148 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.72930485 |
149 | bile acid biosynthetic process (GO:0006699) | 2.72528889 |
150 | immunoglobulin mediated immune response (GO:0016064) | 2.72255399 |
151 | response to type I interferon (GO:0034340) | 2.71324794 |
152 | rRNA metabolic process (GO:0016072) | 2.71236509 |
153 | type I interferon signaling pathway (GO:0060337) | 2.70977220 |
154 | cellular response to type I interferon (GO:0071357) | 2.70977220 |
155 | folic acid-containing compound metabolic process (GO:0006760) | 2.70003048 |
156 | regulation of mitochondrial translation (GO:0070129) | 2.69834253 |
157 | tryptophan metabolic process (GO:0006568) | 2.69754997 |
158 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.67300341 |
159 | response to peptidoglycan (GO:0032494) | 2.66873940 |
160 | leukocyte aggregation (GO:0070486) | 2.63366588 |
161 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63015541 |
162 | regulation of T cell tolerance induction (GO:0002664) | 2.61807100 |
163 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.61257533 |
164 | detection of bacterium (GO:0016045) | 2.59998191 |
165 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59149092 |
166 | regulation of cell killing (GO:0031341) | 2.58593790 |
167 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.58392671 |
168 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.58369543 |
169 | regulation of antigen processing and presentation (GO:0002577) | 2.56916263 |
170 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55789665 |
171 | detection of other organism (GO:0098543) | 2.53297672 |
172 | regulation of interleukin-8 secretion (GO:2000482) | 2.48994050 |
173 | organelle membrane fusion (GO:0090174) | 2.47061469 |
174 | cellular response to exogenous dsRNA (GO:0071360) | 2.46165145 |
175 | myeloid cell activation involved in immune response (GO:0002275) | 2.45464174 |
176 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.45408284 |
177 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45352268 |
178 | actin nucleation (GO:0045010) | 2.45111541 |
179 | positive regulation of cell killing (GO:0031343) | 2.43837312 |
180 | negative regulation of T cell apoptotic process (GO:0070233) | 2.43523334 |
181 | defense response to protozoan (GO:0042832) | 2.43164940 |
182 | lymphocyte chemotaxis (GO:0048247) | 2.42708262 |
183 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.42317727 |
184 | iron-sulfur cluster assembly (GO:0016226) | 2.41322149 |
185 | metallo-sulfur cluster assembly (GO:0031163) | 2.41322149 |
186 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.38486531 |
187 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.38148645 |
188 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.37849810 |
189 | negative regulation of viral genome replication (GO:0045071) | 2.37722722 |
190 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37096115 |
191 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.36954438 |
192 | negative regulation of T cell mediated immunity (GO:0002710) | 2.36637057 |
193 | cellular extravasation (GO:0045123) | 2.35242642 |
194 | regulation of T cell apoptotic process (GO:0070232) | 2.33726413 |
195 | positive regulation of T cell apoptotic process (GO:0070234) | 2.33305954 |
196 | dendritic cell migration (GO:0036336) | 2.33263499 |
197 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.32006161 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.46444376 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.31610698 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.56561944 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52250864 |
5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.45642348 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.33263192 |
7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.27463666 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.21024863 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.20552526 |
10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15369550 |
11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.97275647 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.89393271 |
13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.79940526 |
14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.70044679 |
15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67326419 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64622976 |
17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.61468175 |
18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59128410 |
19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.55797007 |
20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54498152 |
21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46299287 |
22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43141094 |
23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.42411184 |
24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.39683946 |
25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28245802 |
26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.24016963 |
27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22349968 |
28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.17456871 |
29 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.13933415 |
30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03550964 |
31 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.03144252 |
32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.98750209 |
33 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98505090 |
34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95257888 |
35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94033288 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92229271 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90459159 |
38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88386060 |
39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.85973456 |
40 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.84998673 |
41 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84974238 |
42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.84145629 |
43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.83941010 |
44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83451776 |
45 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82605575 |
46 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.81687751 |
47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79219692 |
48 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.79120345 |
49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78827255 |
50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.77959473 |
51 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77829540 |
52 | MAF_26560356_Chip-Seq_TH1_Human | 1.74962538 |
53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74569623 |
54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72449741 |
55 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.72099409 |
56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71847161 |
57 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.70988373 |
58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.70603861 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68557000 |
60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.68035128 |
61 | P68_20966046_ChIP-Seq_HELA_Human | 1.67523845 |
62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65486187 |
63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65359115 |
64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65115996 |
65 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.63952264 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.63831088 |
67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62911468 |
68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.60625781 |
69 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60092084 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59428878 |
71 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.57812242 |
72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56796528 |
73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55992579 |
74 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.55787127 |
75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.55510308 |
76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.55190721 |
77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54645354 |
78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53057607 |
79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52987067 |
80 | MYB_26560356_Chip-Seq_TH2_Human | 1.52820348 |
81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51375717 |
82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51227528 |
83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50976737 |
84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.46866239 |
85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46370587 |
86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46141912 |
87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45696384 |
88 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.44888730 |
89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.43366226 |
90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42389085 |
91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41506972 |
92 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.40025312 |
93 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39102174 |
94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37439953 |
95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.36877561 |
96 | P300_27268052_Chip-Seq_Bcells_Human | 1.36631271 |
97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36304485 |
98 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35627309 |
99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35603829 |
100 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.35321000 |
101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.35009533 |
102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34273628 |
103 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32905337 |
104 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32144158 |
105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31375123 |
106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.31174114 |
107 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30426991 |
108 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.29782233 |
109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28956722 |
110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28882892 |
111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28294887 |
112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28201804 |
113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27070578 |
114 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26571670 |
115 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26101634 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25922371 |
117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25582037 |
118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25124986 |
119 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23676626 |
120 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.23549744 |
121 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.23267194 |
122 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.23090358 |
123 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22968225 |
124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22884984 |
125 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21870744 |
126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.21036484 |
127 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.20324953 |
128 | MYB_26560356_Chip-Seq_TH1_Human | 1.19137674 |
129 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.18844667 |
130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.18419198 |
131 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18291115 |
132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18260518 |
133 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.16915440 |
134 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15952804 |
135 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15779559 |
136 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15586602 |
137 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14975736 |
138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14788768 |
139 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.14577900 |
140 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13785264 |
141 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13751490 |
142 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.13356807 |
143 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11420785 |
144 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11098246 |
145 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.10990504 |
146 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10440398 |
147 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10437552 |
148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10172954 |
149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09549222 |
150 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.08068620 |
151 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06841644 |
152 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06715617 |
153 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06387276 |
154 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06335845 |
155 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05650295 |
156 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05548023 |
157 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05346282 |
158 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04930862 |
159 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04930862 |
160 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04930862 |
161 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04294797 |
162 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03332244 |
163 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03055027 |
164 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02406173 |
165 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02214058 |
166 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99500694 |
167 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97864417 |
168 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97358659 |
169 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95331984 |
170 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95017588 |
171 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.94990872 |
172 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94620515 |
173 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94225124 |
174 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93371029 |
175 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93117947 |
176 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.92688137 |
177 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92474920 |
178 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92385965 |
179 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91440105 |
180 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90269981 |
181 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89675831 |
182 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.87736543 |
183 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.87523429 |
184 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87161250 |
185 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.86422450 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.36464115 |
2 | MP0005365_abnormal_bile_salt | 4.17188105 |
3 | MP0008260_abnormal_autophagy | 3.98621990 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.96318009 |
5 | MP0003436_decreased_susceptibility_to | 3.92853752 |
6 | MP0009840_abnormal_foam_cell | 3.89043013 |
7 | MP0003693_abnormal_embryo_hatching | 3.81286481 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.76010769 |
9 | MP0003724_increased_susceptibility_to | 3.73809204 |
10 | MP0005360_urolithiasis | 3.64129324 |
11 | MP0003718_maternal_effect | 3.45670243 |
12 | MP0005332_abnormal_amino_acid | 3.02099367 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.98591695 |
14 | MP0001835_abnormal_antigen_presentation | 2.96797091 |
15 | MP0005671_abnormal_response_to | 2.87434290 |
16 | MP0009785_altered_susceptibility_to | 2.83820068 |
17 | MP0000685_abnormal_immune_system | 2.62879914 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.60350332 |
19 | MP0004957_abnormal_blastocyst_morpholog | 2.58700431 |
20 | MP0003111_abnormal_nucleus_morphology | 2.53518881 |
21 | MP0005000_abnormal_immune_tolerance | 2.47231703 |
22 | MP0005387_immune_system_phenotype | 2.46878026 |
23 | MP0001790_abnormal_immune_system | 2.46878026 |
24 | MP0001800_abnormal_humoral_immune | 2.43102791 |
25 | MP0005025_abnormal_response_to | 2.41753601 |
26 | MP0003191_abnormal_cellular_cholesterol | 2.39386509 |
27 | MP0002723_abnormal_immune_serum | 2.33956419 |
28 | MP0010329_abnormal_lipoprotein_level | 2.32429011 |
29 | MP0002419_abnormal_innate_immunity | 2.26053207 |
30 | MP0001542_abnormal_bone_strength | 2.24183971 |
31 | MP0005083_abnormal_biliary_tract | 2.17514352 |
32 | MP0005464_abnormal_platelet_physiology | 2.15440789 |
33 | MP0001533_abnormal_skeleton_physiology | 2.12111466 |
34 | MP0002420_abnormal_adaptive_immunity | 2.10798304 |
35 | MP0001819_abnormal_immune_cell | 2.07994921 |
36 | MP0004019_abnormal_vitamin_homeostasis | 2.07665198 |
37 | MP0002452_abnormal_antigen_presenting | 2.05283778 |
38 | MP0001986_abnormal_taste_sensitivity | 2.02491231 |
39 | MP0001666_abnormal_nutrient_absorption | 1.98044884 |
40 | MP0003786_premature_aging | 1.97725807 |
41 | MP0006036_abnormal_mitochondrial_physio | 1.89344853 |
42 | MP0003186_abnormal_redox_activity | 1.88248712 |
43 | MP0005451_abnormal_body_composition | 1.87914038 |
44 | MP0009764_decreased_sensitivity_to | 1.86279198 |
45 | MP0003656_abnormal_erythrocyte_physiolo | 1.84337511 |
46 | MP0003763_abnormal_thymus_physiology | 1.83560654 |
47 | MP0006082_CNS_inflammation | 1.79040492 |
48 | MP0006035_abnormal_mitochondrial_morpho | 1.77956564 |
49 | MP0001661_extended_life_span | 1.77716555 |
50 | MP0003123_paternal_imprinting | 1.75870136 |
51 | MP0003303_peritoneal_inflammation | 1.70830953 |
52 | MP0003077_abnormal_cell_cycle | 1.70409458 |
53 | MP0000609_abnormal_liver_physiology | 1.68241647 |
54 | MP0005319_abnormal_enzyme/_coenzyme | 1.66266218 |
55 | MP0002405_respiratory_system_inflammati | 1.66230911 |
56 | MP0002118_abnormal_lipid_homeostasis | 1.63633066 |
57 | MP0001764_abnormal_homeostasis | 1.59612337 |
58 | MP0001845_abnormal_inflammatory_respons | 1.59493367 |
59 | MP0000716_abnormal_immune_system | 1.58765310 |
60 | MP0003866_abnormal_defecation | 1.54871714 |
61 | MP0010155_abnormal_intestine_physiology | 1.54343669 |
62 | MP0002398_abnormal_bone_marrow | 1.51933073 |
63 | MP0008469_abnormal_protein_level | 1.48242663 |
64 | MP0003646_muscle_fatigue | 1.47927433 |
65 | MP0005395_other_phenotype | 1.47467415 |
66 | MP0002933_joint_inflammation | 1.47013169 |
67 | MP0003172_abnormal_lysosome_physiology | 1.46990594 |
68 | MP0001730_embryonic_growth_arrest | 1.43214199 |
69 | MP0009643_abnormal_urine_homeostasis | 1.43196444 |
70 | MP0001756_abnormal_urination | 1.42222626 |
71 | MP0005670_abnormal_white_adipose | 1.42080890 |
72 | MP0010094_abnormal_chromosome_stability | 1.38737939 |
73 | MP0000689_abnormal_spleen_morphology | 1.37625810 |
74 | MP0008058_abnormal_DNA_repair | 1.36984254 |
75 | MP0002332_abnormal_exercise_endurance | 1.35866586 |
76 | MP0005058_abnormal_lysosome_morphology | 1.33649349 |
77 | MP0002429_abnormal_blood_cell | 1.30910266 |
78 | MP0003075_altered_response_to | 1.29842367 |
79 | MP0003195_calcinosis | 1.28240411 |
80 | MP0002722_abnormal_immune_system | 1.28011781 |
81 | MP0002269_muscular_atrophy | 1.26854194 |
82 | MP0000747_muscle_weakness | 1.24911880 |
83 | MP0008057_abnormal_DNA_replication | 1.20284581 |
84 | MP0002132_abnormal_respiratory_system | 1.18848069 |
85 | MP0000358_abnormal_cell_content/ | 1.17357042 |
86 | MP0004947_skin_inflammation | 1.17308008 |
87 | MP0002277_abnormal_respiratory_mucosa | 1.17293877 |
88 | MP0003011_delayed_dark_adaptation | 1.17208152 |
89 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16553095 |
90 | MP0008932_abnormal_embryonic_tissue | 1.14392675 |
91 | MP0004084_abnormal_cardiac_muscle | 1.10930197 |
92 | MP0001672_abnormal_embryogenesis/_devel | 1.08562798 |
93 | MP0005380_embryogenesis_phenotype | 1.08562798 |
94 | MP0001545_abnormal_hematopoietic_system | 1.07526536 |
95 | MP0005397_hematopoietic_system_phenotyp | 1.07526536 |
96 | MP0003828_pulmonary_edema | 1.07448657 |
97 | MP0005075_abnormal_melanosome_morpholog | 1.07004242 |
98 | MP0000343_altered_response_to | 1.06400685 |
99 | MP0005390_skeleton_phenotype | 1.05797588 |
100 | MP0000598_abnormal_liver_morphology | 1.02033668 |
101 | MP0005330_cardiomyopathy | 1.00957020 |
102 | MP0003252_abnormal_bile_duct | 1.00119015 |
103 | MP0000703_abnormal_thymus_morphology | 1.00005337 |
104 | MP0000750_abnormal_muscle_regeneration | 0.99926086 |
105 | MP0005636_abnormal_mineral_homeostasis | 0.99741788 |
106 | MP0000015_abnormal_ear_pigmentation | 0.97184707 |
107 | MP0003984_embryonic_growth_retardation | 0.96287967 |
108 | MP0000604_amyloidosis | 0.96163430 |
109 | MP0000350_abnormal_cell_proliferation | 0.95351611 |
110 | MP0002080_prenatal_lethality | 0.94044488 |
111 | MP0009278_abnormal_bone_marrow | 0.93643695 |
112 | MP0002396_abnormal_hematopoietic_system | 0.92820408 |
113 | MP0002088_abnormal_embryonic_growth/wei | 0.92760705 |
114 | MP0004381_abnormal_hair_follicle | 0.91041314 |
115 | MP0004510_myositis | 0.90897595 |
116 | MP0009333_abnormal_splenocyte_physiolog | 0.89649086 |
117 | MP0003941_abnormal_skin_development | 0.89292634 |
118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88290321 |
119 | MP0000858_altered_metastatic_potential | 0.88145444 |
120 | MP0002138_abnormal_hepatobiliary_system | 0.87769678 |
121 | MP0005376_homeostasis/metabolism_phenot | 0.86861262 |
122 | MP0005266_abnormal_metabolism | 0.86598243 |
123 | MP0008007_abnormal_cellular_replicative | 0.85852465 |
124 | MP0001873_stomach_inflammation | 0.85260756 |
125 | MP0005166_decreased_susceptibility_to | 0.85107970 |
126 | MP0004782_abnormal_surfactant_physiolog | 0.84699699 |
127 | MP0004264_abnormal_extraembryonic_tissu | 0.84633932 |
128 | MP0000465_gastrointestinal_hemorrhage | 0.83850444 |
129 | MP0001663_abnormal_digestive_system | 0.82902918 |
130 | MP0001697_abnormal_embryo_size | 0.82360318 |
131 | MP0002998_abnormal_bone_remodeling | 0.79504301 |
132 | MP0002796_impaired_skin_barrier | 0.79252529 |
133 | MP0001853_heart_inflammation | 0.77734287 |
134 | MP0010368_abnormal_lymphatic_system | 0.77632024 |
135 | MP0002102_abnormal_ear_morphology | 0.77172519 |
136 | MP0009763_increased_sensitivity_to | 0.75916056 |
137 | MP0008872_abnormal_physiological_respon | 0.75642962 |
138 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75428295 |
139 | MP0005165_increased_susceptibility_to | 0.75217444 |
140 | MP0004883_abnormal_blood_vessel | 0.74364600 |
141 | MP0005174_abnormal_tail_pigmentation | 0.73966296 |
142 | MP0008995_early_reproductive_senescence | 0.72228029 |
143 | MP0003279_aneurysm | 0.72207245 |
144 | MP0002136_abnormal_kidney_physiology | 0.71624612 |
145 | MP0002086_abnormal_extraembryonic_tissu | 0.71029246 |
146 | MP0009697_abnormal_copulation | 0.69961727 |
147 | MP0001958_emphysema | 0.69234582 |
148 | MP0003329_amyloid_beta_deposits | 0.67712265 |
149 | MP0003879_abnormal_hair_cell | 0.67588204 |
150 | MP0001905_abnormal_dopamine_level | 0.67318831 |
151 | MP0006138_congestive_heart_failure | 0.67246566 |
152 | MP0002254_reproductive_system_inflammat | 0.67132898 |
153 | MP0004043_abnormal_pH_regulation | 0.66802597 |
154 | MP0004147_increased_porphyrin_level | 0.66381831 |
155 | MP0005384_cellular_phenotype | 0.62651679 |
156 | MP0009672_abnormal_birth_weight | 0.62034487 |
157 | MP0002876_abnormal_thyroid_physiology | 0.61707180 |
158 | MP0004036_abnormal_muscle_relaxation | 0.61020094 |
159 | MP0005621_abnormal_cell_physiology | 0.60975716 |
160 | MP0009642_abnormal_blood_homeostasis | 0.60517259 |
161 | MP0003878_abnormal_ear_physiology | 0.60506077 |
162 | MP0005377_hearing/vestibular/ear_phenot | 0.60506077 |
163 | MP0004130_abnormal_muscle_cell | 0.59287900 |
164 | MP0002653_abnormal_ependyma_morphology | 0.58990117 |
165 | MP0000313_abnormal_cell_death | 0.58911861 |
166 | MP0009765_abnormal_xenobiotic_induced | 0.58413219 |
167 | MP0002127_abnormal_cardiovascular_syste | 0.58121399 |
168 | MP0005220_abnormal_exocrine_pancreas | 0.57688499 |
169 | MP0002019_abnormal_tumor_incidence | 0.56739959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperglycinemia (HP:0002154) | 6.56742220 |
2 | Hyperglycinuria (HP:0003108) | 6.00469786 |
3 | Gout (HP:0001997) | 5.72394859 |
4 | Abnormality of glycine metabolism (HP:0010895) | 5.35586294 |
5 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.35586294 |
6 | Cerebral hypomyelination (HP:0006808) | 4.50630447 |
7 | Myositis (HP:0100614) | 4.49392124 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36644050 |
9 | Abnormality of serum amino acid levels (HP:0003112) | 4.31223496 |
10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24429398 |
11 | Stomatitis (HP:0010280) | 4.11962480 |
12 | Orchitis (HP:0100796) | 3.88776956 |
13 | Birth length less than 3rd percentile (HP:0003561) | 3.88093309 |
14 | Breast hypoplasia (HP:0003187) | 3.73839750 |
15 | Optic neuritis (HP:0100653) | 3.57939446 |
16 | Retrobulbar optic neuritis (HP:0100654) | 3.57939446 |
17 | Carpal bone hypoplasia (HP:0001498) | 3.51672205 |
18 | Abnormality of macrophages (HP:0004311) | 3.44628810 |
19 | Gastrointestinal infarctions (HP:0005244) | 3.40676480 |
20 | Hypobetalipoproteinemia (HP:0003563) | 3.36350511 |
21 | Eczematoid dermatitis (HP:0000976) | 3.31312123 |
22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24597755 |
23 | Progressive muscle weakness (HP:0003323) | 3.23099698 |
24 | Multiple enchondromatosis (HP:0005701) | 3.20285689 |
25 | Hyperlipoproteinemia (HP:0010980) | 3.20056509 |
26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.19587140 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.18053249 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.18053249 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.18053249 |
30 | Ureteral duplication (HP:0000073) | 3.17383868 |
31 | Recurrent abscess formation (HP:0002722) | 3.13678979 |
32 | Recurrent bacterial skin infections (HP:0005406) | 3.12238820 |
33 | Lethargy (HP:0001254) | 3.04972536 |
34 | Recurrent fungal infections (HP:0002841) | 3.04898302 |
35 | Hyperammonemia (HP:0001987) | 3.02208953 |
36 | Impulsivity (HP:0100710) | 2.99286370 |
37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.97740730 |
38 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.96771102 |
39 | Abnormality of the umbilical cord (HP:0010881) | 2.96101507 |
40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95265334 |
41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95265334 |
42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92098518 |
43 | Obstructive lung disease (HP:0006536) | 2.92098518 |
44 | Encephalitis (HP:0002383) | 2.90044111 |
45 | Increased purine levels (HP:0004368) | 2.87782040 |
46 | Hyperuricemia (HP:0002149) | 2.87782040 |
47 | Xanthomatosis (HP:0000991) | 2.86508287 |
48 | Death in infancy (HP:0001522) | 2.85832063 |
49 | Atrioventricular block (HP:0001678) | 2.81775852 |
50 | Pulmonary infiltrates (HP:0002113) | 2.81391980 |
51 | Delusions (HP:0000746) | 2.78928159 |
52 | Megaloblastic anemia (HP:0001889) | 2.78423754 |
53 | CNS hypomyelination (HP:0003429) | 2.78314693 |
54 | Intrahepatic cholestasis (HP:0001406) | 2.78234861 |
55 | Tetraplegia (HP:0002445) | 2.76907860 |
56 | Rough bone trabeculation (HP:0100670) | 2.76329100 |
57 | Dicarboxylic aciduria (HP:0003215) | 2.71529687 |
58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71529687 |
59 | Mediastinal lymphadenopathy (HP:0100721) | 2.70499994 |
60 | Increased serum ferritin (HP:0003281) | 2.70440140 |
61 | Petechiae (HP:0000967) | 2.70093458 |
62 | Deep venous thrombosis (HP:0002625) | 2.65620119 |
63 | Hypochromic anemia (HP:0001931) | 2.64055289 |
64 | Increased IgM level (HP:0003496) | 2.63541262 |
65 | CNS demyelination (HP:0007305) | 2.63082568 |
66 | Recurrent skin infections (HP:0001581) | 2.62298268 |
67 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.59032551 |
68 | Episodic fever (HP:0001954) | 2.56295738 |
69 | Secondary amenorrhea (HP:0000869) | 2.56074518 |
70 | Meningitis (HP:0001287) | 2.54014308 |
71 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.53512246 |
72 | Hypochromic microcytic anemia (HP:0004840) | 2.53168233 |
73 | Premature ovarian failure (HP:0008209) | 2.52213957 |
74 | Hyperglycemia (HP:0003074) | 2.50974863 |
75 | Areflexia of lower limbs (HP:0002522) | 2.50804424 |
76 | Prolonged partial thromboplastin time (HP:0003645) | 2.50495805 |
77 | T lymphocytopenia (HP:0005403) | 2.49562910 |
78 | Abnormality of iron homeostasis (HP:0011031) | 2.47098145 |
79 | Dysostosis multiplex (HP:0000943) | 2.46892932 |
80 | IgG deficiency (HP:0004315) | 2.46594064 |
81 | Abnormality of T cells (HP:0002843) | 2.46520688 |
82 | Abnormality of purine metabolism (HP:0004352) | 2.45824792 |
83 | Abnormality of T cell number (HP:0011839) | 2.44595986 |
84 | Polycythemia (HP:0001901) | 2.44581691 |
85 | Urticaria (HP:0001025) | 2.42141640 |
86 | Vasculitis (HP:0002633) | 2.41638426 |
87 | Entropion (HP:0000621) | 2.41635891 |
88 | Pustule (HP:0200039) | 2.41430043 |
89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39596720 |
90 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39596720 |
91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39596720 |
92 | Irritability (HP:0000737) | 2.39465972 |
93 | Hyperalaninemia (HP:0003348) | 2.38081371 |
94 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.38081371 |
95 | Abnormality of alanine metabolism (HP:0010916) | 2.38081371 |
96 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36923066 |
97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36020302 |
98 | Anorexia (HP:0002039) | 2.35207355 |
99 | Keratoconjunctivitis sicca (HP:0001097) | 2.34370659 |
100 | Keratoconjunctivitis (HP:0001096) | 2.33475993 |
101 | Hemoptysis (HP:0002105) | 2.33322685 |
102 | Prolonged bleeding time (HP:0003010) | 2.32358753 |
103 | Hypolipoproteinemia (HP:0010981) | 2.31747839 |
104 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.31257259 |
105 | Increased IgE level (HP:0003212) | 2.30836059 |
106 | Muscle fiber splitting (HP:0003555) | 2.29260959 |
107 | Global brain atrophy (HP:0002283) | 2.28871544 |
108 | Abnormal cartilage morphology (HP:0002763) | 2.28476218 |
109 | Abnormality of T cell physiology (HP:0011840) | 2.28366326 |
110 | Purpura (HP:0000979) | 2.28309699 |
111 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27203935 |
112 | Hypertensive crisis (HP:0100735) | 2.22484040 |
113 | Brushfield spots (HP:0001088) | 2.20714465 |
114 | Leukocytosis (HP:0001974) | 2.19920400 |
115 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.19119613 |
116 | Panhypogammaglobulinemia (HP:0003139) | 2.18802327 |
117 | Cerebral palsy (HP:0100021) | 2.17996313 |
118 | Microcytic anemia (HP:0001935) | 2.17494140 |
119 | Chest pain (HP:0100749) | 2.15135523 |
120 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.13846319 |
121 | Degeneration of anterior horn cells (HP:0002398) | 2.13372870 |
122 | Abnormality of the anterior horn cell (HP:0006802) | 2.13372870 |
123 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12499444 |
124 | Patent foramen ovale (HP:0001655) | 2.12197754 |
125 | Vacuolated lymphocytes (HP:0001922) | 2.12186260 |
126 | Granulocytopenia (HP:0001913) | 2.12143038 |
127 | Microretrognathia (HP:0000308) | 2.08394293 |
128 | Sparse eyelashes (HP:0000653) | 2.07014231 |
129 | Acne (HP:0001061) | 2.06687451 |
130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06438623 |
131 | Metabolic acidosis (HP:0001942) | 2.05114228 |
132 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04726476 |
133 | Delayed CNS myelination (HP:0002188) | 2.04384875 |
134 | Keratitis (HP:0000491) | 2.03980027 |
135 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.02569719 |
136 | Prolonged neonatal jaundice (HP:0006579) | 2.02094124 |
137 | Joint swelling (HP:0001386) | 2.01440741 |
138 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01261373 |
139 | Mucopolysacchariduria (HP:0008155) | 2.01261373 |
140 | Malnutrition (HP:0004395) | 2.00741642 |
141 | Abnormal hemoglobin (HP:0011902) | 2.00740534 |
142 | Patellar aplasia (HP:0006443) | 2.00647544 |
143 | Epistaxis (HP:0000421) | 1.99984320 |
144 | Abnormality of the intrinsic pathway (HP:0010989) | 1.99520168 |
145 | Postnatal microcephaly (HP:0005484) | 1.99467066 |
146 | Spastic diplegia (HP:0001264) | 1.99304109 |
147 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.98951609 |
148 | Nausea (HP:0002018) | 1.98298375 |
149 | Abnormality of methionine metabolism (HP:0010901) | 1.97695762 |
150 | Ketosis (HP:0001946) | 1.97469732 |
151 | Increased cerebral lipofuscin (HP:0011813) | 1.95667559 |
152 | Abnormality of the pericardium (HP:0001697) | 1.95504960 |
153 | Gingival bleeding (HP:0000225) | 1.94660066 |
154 | Muscle fibrillation (HP:0010546) | 1.94027047 |
155 | Tongue fasciculations (HP:0001308) | 1.93691221 |
156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93539081 |
157 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93492208 |
158 | Increased muscle lipid content (HP:0009058) | 1.91341083 |
159 | Hepatosplenomegaly (HP:0001433) | 1.90932155 |
160 | Abnormal trabecular bone morphology (HP:0100671) | 1.90706878 |
161 | Restlessness (HP:0000711) | 1.90704129 |
162 | Hypoglycemic coma (HP:0001325) | 1.89770419 |
163 | Inflammation of the large intestine (HP:0002037) | 1.88011430 |
164 | Abnormality of the pleura (HP:0002103) | 1.86513177 |
165 | Personality changes (HP:0000751) | 1.86439634 |
166 | Vertebral compression fractures (HP:0002953) | 1.86328793 |
167 | Increased serum pyruvate (HP:0003542) | 1.85707845 |
168 | Abnormality of glycolysis (HP:0004366) | 1.85707845 |
169 | Fat malabsorption (HP:0002630) | 1.85543207 |
170 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84683771 |
171 | Bundle branch block (HP:0011710) | 1.83751284 |
172 | Hypergammaglobulinemia (HP:0010702) | 1.83423467 |
173 | Myopathic facies (HP:0002058) | 1.82514609 |
174 | Recurrent viral infections (HP:0004429) | 1.82181023 |
175 | Hepatic necrosis (HP:0002605) | 1.81868115 |
176 | Oral leukoplakia (HP:0002745) | 1.80937752 |
177 | Skin rash (HP:0000988) | 1.80386585 |
178 | Gangrene (HP:0100758) | 1.79739254 |
179 | Amyloidosis (HP:0011034) | 1.79265585 |
180 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78792821 |
181 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78481370 |
182 | Steatorrhea (HP:0002570) | 1.78367739 |
183 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78365117 |
184 | Emotional lability (HP:0000712) | 1.78330943 |
185 | Brittle hair (HP:0002299) | 1.78279075 |
186 | Complement deficiency (HP:0004431) | 1.78051485 |
187 | Agammaglobulinemia (HP:0004432) | 1.77656599 |
188 | Severe visual impairment (HP:0001141) | 1.77244795 |
189 | Stenosis of the external auditory canal (HP:0000402) | 1.77126288 |
190 | Eosinophilia (HP:0001880) | 1.75323272 |
191 | Mitochondrial inheritance (HP:0001427) | 1.75310201 |
192 | Gastrointestinal inflammation (HP:0004386) | 1.74490560 |
193 | Abnormality of eosinophils (HP:0001879) | 1.74195685 |
194 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.73393453 |
195 | Vertigo (HP:0002321) | 1.71528917 |
196 | Acute hepatic failure (HP:0006554) | 1.70314392 |
197 | Peritonitis (HP:0002586) | 1.70304846 |
198 | Albinism (HP:0001022) | 1.70164073 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 5.27602259 |
2 | WEE1 | 4.89868727 |
3 | AKT3 | 4.44298477 |
4 | TSSK6 | 3.79122107 |
5 | TXK | 3.31668363 |
6 | BCKDK | 3.26574422 |
7 | EPHA2 | 3.07745835 |
8 | NME2 | 2.72902306 |
9 | STK16 | 2.64908763 |
10 | PINK1 | 2.62585207 |
11 | RIPK4 | 2.40924619 |
12 | ARAF | 2.39378745 |
13 | PDK4 | 2.30748979 |
14 | PDK3 | 2.30748979 |
15 | EIF2AK1 | 2.22692897 |
16 | TAOK3 | 2.21780688 |
17 | NEK1 | 2.20044189 |
18 | TBK1 | 2.18129685 |
19 | TYK2 | 2.02425611 |
20 | IRAK4 | 2.01171252 |
21 | BRSK2 | 1.98932779 |
22 | PNCK | 1.95382757 |
23 | TNK2 | 1.91366410 |
24 | PIM2 | 1.86422299 |
25 | FES | 1.85553575 |
26 | BLK | 1.78688249 |
27 | MAP3K11 | 1.77578249 |
28 | IKBKE | 1.75703261 |
29 | IKBKB | 1.73856286 |
30 | PLK4 | 1.71631753 |
31 | TLK1 | 1.71164923 |
32 | DYRK3 | 1.69272658 |
33 | PDK2 | 1.65744171 |
34 | NEK2 | 1.61293605 |
35 | BRAF | 1.57222373 |
36 | TESK1 | 1.54830412 |
37 | ZAK | 1.54364859 |
38 | JAK3 | 1.53213191 |
39 | ADRBK2 | 1.53107218 |
40 | EIF2AK3 | 1.50166366 |
41 | PLK1 | 1.44975733 |
42 | EPHB1 | 1.44904613 |
43 | CCNB1 | 1.44421109 |
44 | LIMK1 | 1.42584202 |
45 | CSK | 1.40656383 |
46 | TTK | 1.38361817 |
47 | MAPKAPK3 | 1.35508266 |
48 | SYK | 1.34838268 |
49 | ACVR1B | 1.34284587 |
50 | MAP2K2 | 1.31617647 |
51 | BRSK1 | 1.30355538 |
52 | PLK3 | 1.25857556 |
53 | SRPK1 | 1.18880534 |
54 | TAOK2 | 1.15154635 |
55 | BTK | 1.13409281 |
56 | MAP3K3 | 1.10681917 |
57 | PTK2B | 1.09101306 |
58 | MAP2K6 | 1.08196901 |
59 | TAOK1 | 1.06354367 |
60 | GRK7 | 1.06080227 |
61 | MARK3 | 1.03868720 |
62 | HCK | 1.02306474 |
63 | LYN | 1.02126070 |
64 | ADRBK1 | 1.00654850 |
65 | MAP2K3 | 0.98894060 |
66 | GRK5 | 0.97718767 |
67 | MAPK12 | 0.95178513 |
68 | MAP3K1 | 0.94619620 |
69 | PRKD2 | 0.94361771 |
70 | LCK | 0.92049104 |
71 | ITK | 0.88665193 |
72 | AURKA | 0.88112129 |
73 | FGFR4 | 0.84053652 |
74 | KIT | 0.82784193 |
75 | MATK | 0.82692574 |
76 | MYLK | 0.82161971 |
77 | SIK2 | 0.80863765 |
78 | PRPF4B | 0.80640522 |
79 | PRKCQ | 0.80448506 |
80 | AURKB | 0.79395055 |
81 | PRKCI | 0.79335522 |
82 | ERN1 | 0.77567435 |
83 | CAMKK1 | 0.74009315 |
84 | CDC42BPA | 0.73545190 |
85 | NME1 | 0.73301487 |
86 | LATS2 | 0.72903640 |
87 | CSF1R | 0.72515682 |
88 | MKNK2 | 0.72256285 |
89 | IRAK1 | 0.72129936 |
90 | PIM1 | 0.70872981 |
91 | ALK | 0.70868976 |
92 | MAP3K8 | 0.70529434 |
93 | IRAK3 | 0.70331006 |
94 | CHEK2 | 0.69349284 |
95 | CDK7 | 0.69255069 |
96 | PHKG1 | 0.68801226 |
97 | PHKG2 | 0.68801226 |
98 | PAK1 | 0.67707510 |
99 | TRIB3 | 0.66338698 |
100 | CSNK1G3 | 0.66168829 |
101 | MAP3K14 | 0.65908444 |
102 | PTK6 | 0.65746710 |
103 | JAK1 | 0.65675952 |
104 | CSNK1G1 | 0.62206188 |
105 | MAP2K1 | 0.61351642 |
106 | BMX | 0.61155443 |
107 | BMPR2 | 0.60317649 |
108 | MAP3K12 | 0.60073251 |
109 | JAK2 | 0.59375624 |
110 | RPS6KB2 | 0.59299963 |
111 | BMPR1B | 0.59077611 |
112 | SIK3 | 0.58124615 |
113 | RPS6KA6 | 0.57157349 |
114 | ZAP70 | 0.55841751 |
115 | MARK2 | 0.55434785 |
116 | RPS6KA4 | 0.55280526 |
117 | PIK3CG | 0.54874508 |
118 | CDK4 | 0.54274287 |
119 | MAP3K9 | 0.53971149 |
120 | ABL2 | 0.53724426 |
121 | CAMKK2 | 0.52657477 |
122 | TESK2 | 0.52293550 |
123 | RAF1 | 0.52230599 |
124 | TIE1 | 0.51647866 |
125 | MAPKAPK2 | 0.50701619 |
126 | GRK6 | 0.50484726 |
127 | HIPK2 | 0.50484209 |
128 | MAPK7 | 0.50425126 |
129 | CDK19 | 0.50247565 |
130 | NUAK1 | 0.49012814 |
131 | WNK4 | 0.47686741 |
132 | RPS6KA5 | 0.47136403 |
133 | PDK1 | 0.45863815 |
134 | TGFBR2 | 0.45389667 |
135 | MAP3K7 | 0.42753585 |
136 | MAPK11 | 0.41960034 |
137 | STK38L | 0.41935604 |
138 | PRKAA1 | 0.41859927 |
139 | LRRK2 | 0.40289372 |
140 | CAMK2G | 0.39361874 |
141 | CHUK | 0.39121563 |
142 | PAK4 | 0.37582297 |
143 | DAPK2 | 0.37522621 |
144 | CSNK2A1 | 0.36960689 |
145 | STK3 | 0.36103742 |
146 | STK10 | 0.35528370 |
147 | CSNK2A2 | 0.35313452 |
148 | GRK1 | 0.33909071 |
149 | STK24 | 0.33249936 |
150 | CSNK1E | 0.31626628 |
151 | CSNK1G2 | 0.30921775 |
152 | CSNK1A1L | 0.29417027 |
153 | CDK2 | 0.28165225 |
154 | PRKCG | 0.28059290 |
155 | EIF2AK2 | 0.27174128 |
156 | PDPK1 | 0.25123569 |
157 | MKNK1 | 0.25022698 |
158 | KDR | 0.24754467 |
159 | CHEK1 | 0.23406025 |
160 | DAPK3 | 0.22097746 |
161 | MAPK4 | 0.21945473 |
162 | DAPK1 | 0.21488525 |
163 | MOS | 0.21474683 |
164 | OXSR1 | 0.20538460 |
165 | MAP4K1 | 0.19867106 |
166 | CSNK1A1 | 0.19336332 |
167 | CDK6 | 0.18982215 |
168 | VRK1 | 0.18436637 |
169 | OBSCN | 0.18133199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.98008520 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.19669176 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.13452922 |
4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.06009756 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 3.04015655 |
6 | Proteasome_Homo sapiens_hsa03050 | 2.91081705 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86156053 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.80638248 |
9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.80558602 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.73990613 |
11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.55437863 |
12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.43590227 |
13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36181051 |
14 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.33455709 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28844159 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14109065 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.10857724 |
18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05221160 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04072496 |
20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03547363 |
21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.98711819 |
22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.97059922 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96344433 |
24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92659259 |
25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.92532434 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89856150 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87910325 |
28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86042371 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83880057 |
30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83865728 |
31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79662747 |
32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79201476 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76929682 |
34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.76447109 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72751981 |
36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72013585 |
37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.71689207 |
38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66765920 |
39 | RNA transport_Homo sapiens_hsa03013 | 1.62344764 |
40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.62064575 |
41 | Asthma_Homo sapiens_hsa05310 | 1.59146305 |
42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58847984 |
43 | Malaria_Homo sapiens_hsa05144 | 1.54855163 |
44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.53326394 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.52249328 |
46 | Ribosome_Homo sapiens_hsa03010 | 1.50916557 |
47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.48689604 |
48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.46030209 |
49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45399785 |
50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45173109 |
51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43059199 |
52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42340311 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42299086 |
54 | Tuberculosis_Homo sapiens_hsa05152 | 1.40880948 |
55 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.40702717 |
56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40464535 |
57 | Measles_Homo sapiens_hsa05162 | 1.33648382 |
58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.33274042 |
59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33217702 |
60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.32381230 |
61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31780797 |
62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29278116 |
63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28529926 |
64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.28086432 |
65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27461404 |
66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26948450 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26237402 |
68 | Peroxisome_Homo sapiens_hsa04146 | 1.23891623 |
69 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20596748 |
70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19313442 |
71 | DNA replication_Homo sapiens_hsa03030 | 1.19233522 |
72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15368624 |
73 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14997727 |
74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14585302 |
75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14379788 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10901089 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08159767 |
78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07136152 |
79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05191442 |
80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04071382 |
81 | Purine metabolism_Homo sapiens_hsa00230 | 1.03817053 |
82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02383402 |
83 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01567142 |
84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01055163 |
85 | Pertussis_Homo sapiens_hsa05133 | 1.00090636 |
86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97702953 |
87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96376551 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95857550 |
89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94049290 |
90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93852003 |
91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93478392 |
92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92620001 |
93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92411950 |
94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.91982497 |
95 | Spliceosome_Homo sapiens_hsa03040 | 0.89080065 |
96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88209496 |
97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87187152 |
98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85692420 |
99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85212795 |
100 | Cell cycle_Homo sapiens_hsa04110 | 0.84544102 |
101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83565928 |
102 | Influenza A_Homo sapiens_hsa05164 | 0.82415096 |
103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81206476 |
104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80386270 |
105 | Mismatch repair_Homo sapiens_hsa03430 | 0.80281648 |
106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79487052 |
107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79383775 |
108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78549345 |
109 | Base excision repair_Homo sapiens_hsa03410 | 0.77679603 |
110 | Shigellosis_Homo sapiens_hsa05131 | 0.77035181 |
111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76293099 |
112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74989990 |
113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72948597 |
114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72898857 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70421403 |
116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70239159 |
117 | Apoptosis_Homo sapiens_hsa04210 | 0.70109111 |
118 | Homologous recombination_Homo sapiens_hsa03440 | 0.68192572 |
119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68156218 |
120 | Phagosome_Homo sapiens_hsa04145 | 0.67853616 |
121 | Legionellosis_Homo sapiens_hsa05134 | 0.65696073 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63484126 |
123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62455214 |
124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62372290 |
125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61191665 |
126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60321969 |
127 | Hepatitis C_Homo sapiens_hsa05160 | 0.59876451 |
128 | Salmonella infection_Homo sapiens_hsa05132 | 0.58679988 |
129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58174595 |
130 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55368600 |
131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55344624 |
132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54931946 |
133 | Endocytosis_Homo sapiens_hsa04144 | 0.53298182 |
134 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49975178 |
135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49869728 |
136 | Platelet activation_Homo sapiens_hsa04611 | 0.48235044 |
137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45865313 |
138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44899453 |
139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44645880 |
140 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43858318 |
141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42148998 |
142 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42120625 |
143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41206734 |
144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40205894 |
145 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39561416 |
146 | ABC transporters_Homo sapiens_hsa02010 | 0.38798049 |
147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37227569 |
148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36739498 |
149 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36182406 |
150 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36117814 |
151 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35635564 |
152 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34674994 |
153 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33019060 |
154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32261419 |
155 | Lysosome_Homo sapiens_hsa04142 | 0.30023504 |
156 | Hepatitis B_Homo sapiens_hsa05161 | 0.28769649 |
157 | Bile secretion_Homo sapiens_hsa04976 | 0.28460604 |
158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28422396 |
159 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26375370 |
160 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24990694 |
161 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.24231201 |
162 | Insulin resistance_Homo sapiens_hsa04931 | 0.24110353 |
163 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24101733 |
164 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23655469 |
165 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21254530 |
166 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19816091 |
167 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.19057640 |